Wellstat Ophthalmics Corporation
Wellstat Ophthalmics Corporation, formerly known as AVT, is a privately held company located in Gaithersburg, Maryland. The Company is developing therapies for major sight-threatening diseases. The Company's lead indications under investigation include all forms of age-related macular degeneration.
The Company’s technology addresses inflammation from dysregulation of the innate immune system, a common cause for these diseases. The Company is working to develop a novel anti-inflammatory protein that would be delivered via periodic intravitreal injections. Subsequently, the product would be delivered with Wellstat Ophthalmics' proprietary gene transfer system to achieve sustained therapy with a single administration.